Clinical monographs, dosing protocols, and verified supply for androgenetic alopecia, hair restoration, and urological therapeutics.

Pharmaceutical Grade Direct Supply

Standard Dosage: Standard Clinical Dosage

$0.38 / unit

Direct supply with laboratory Certificate of Analysis (CoA), GMP certified manufacturing, discrete domestic courier dispatch with tracking.

Access Verified Clinical Inventory & Order

Pharmacology & Mechanism of Action

Androgenetic follicular miniaturization is predominantly mediated by the binding of dihydrotestosterone (DHT) to susceptible androgen receptors in the dermal papilla. Therapeutic intervention via Clinical Trichology & Andrology Institute Directory targets key biochemical cascades to reverse progressive follicle dormancy.

Enzymatic Inhibition: Systemic down-regulation of 5-alpha reductase prevents conversion of circulating testosterone into follicular DHT.
Anagen Prolongation: Enhances microvascular perfusion to the dermal papilla, stimulating early entry into active growth phase.
Follicular Diameter Gain: Restores terminal hair morphology over consecutive hair cycles with measurable density improvement.

Administration & Safety Monitoring

Optimal therapeutic outcomes require disciplined daily administration:

Baseline Evaluation: Photographic tracking and serum hormone profile baseline before protocol initiation.
Daily Dosing: Administer Standard Clinical Dosage consistently at the same time each day, regardless of meal timing.
Expected Horizon: Initial shedding reduction observed at 8-12 weeks; peak follicular recovery achieved at 6-12 months.